CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Mar. 31, 2024	Sep. 30, 2023
Current assets:
Cash and cash equivalents	$ 34,738,038	$ 9,625,494
Accounts receivable, net	2,785,331	4,506,508
Inventories, net	4,804,665	6,697,117
Prepaid research and development costs	924,583	1,006,252
Prepaid expenses and other current assets	1,884,684	1,097,851
Total current assets	45,137,301	22,933,222
Plant and equipment, net	1,534,196	1,652,732
Operating lease right-of-use assets	3,947,417	4,332,473
Investments in equity securities	346,444
Deferred income taxes	12,635,927	12,707,419
Goodwill	6,878,932	6,878,932
Other assets	1,320,142	1,518,313
Total assets	71,800,359	50,023,091
Current liabilities:
Accounts payable	2,464,135	12,931,172
Accrued compensation	2,683,214	990,609
Accrued expenses and other current liabilities	2,425,385	1,987,738
Residual royalty agreement liability, short-term portion	950,600	864,623
Operating lease liability, short-term portion	1,043,029	1,036,590
Total current liabilities	9,566,363	17,810,732
Residual royalty agreement liability, long-term portion	8,775,284	8,870,136
Operating lease liability, long-term portion	3,262,818	3,634,114
Other liabilities	4,986,250	29,948
Total liabilities	26,590,715	30,344,930
Commitments and contingencies (Note 12)
Stockholders' equity:
Preferred stock; no shares issued and outstanding at March 31, 2024 and September 30, 2023
Common stock, par value $0.01 per share; 308,000,000 shares authorized, 148,564,890 and 93,966,402 shares issued and 146,381,186 and 91,782,698 shares outstanding at March 31, 2024 and September 30, 2023, respectively	1,485,649	939,664
Additional paid-in-capital	327,182,257	283,894,830
Accumulated other comprehensive loss	(581,519)	(581,519)
Accumulated deficit	(275,070,138)	(256,768,209)
Treasury stock, 2,183,704 shares, at cost	(7,806,605)	(7,806,605)
Total stockholders' equity	45,209,644	19,678,161
Total liabilities and stockholders' equity	$ 71,800,359	$ 50,023,091